SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

A Q3 earnings beat, stronger-than-expected Q4 guidance and expanded buyback authorization sparked a sharp rally, but the move faded as traders focused on cautious management commentary and continued growth and margin concerns. The community is split between seeing short-squeeze potential and viewing the reversal as a warning about the business outlook and management credibility.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is drawing attention after a disappointing Q3 report, with an unexpected loss, compressed margins, and reduced profit guidance weighing on shares despite strong revenue growth. Traders are split between concern about profitability and subscriber trends and optimism around international expansion, branded weight-loss drug partnerships, and potential peptide offerings.

Digital Turbine, Inc. engages in mobile growth platform solutions for advertisers, publishers, carriers, and device original equipment manufacturers. It operates through the following segments: On Device Solutions and App Growth Platform. The On Device Solutions segment consists of products and services that simplify the discovery and delivery of mobile apps and content media for device end users. The App Growth Platform segment provides Advertising Solutions and Ad Monetization Solutions. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

Digital Turbines quarterly results and raised revenue outlook are driving attention, with traders pointing to strong growth and improving business momentum. The reaction is divided: bulls see a turnaround taking hold, while others focus on compressed margins, limited EBITDA improvement, debt, and accounting concerns.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is drawing attention after CEO Jensen Huang acknowledged a relationship with a Megaspeed executive reportedly suspected of Chinese intelligence ties, prompting a board investigation and shareholder lawsuit. Traders are split between treating the controversy as a temporary distraction and buying the dip based on Nvidias AI-chip business, and worrying about governance, regulatory fallout or Huangs future as CEO; the stocks weakness during a broader chip rally has intensified the debate.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,203,846.69715353. The last known price of Ethereum is 2,121.02700944 USD and is down -0.91 over the last 24 hours. It is currently trading on 14303 active market(s) with $13,174,532,202.61 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereums sharp weakness amid a broader crypto selloffand its underperformance versus stocks and, at times, Bitcoinis driving discussion, with traders pointing to liquidations and fund outflows while debating whether the decline is nearing a bottom. Bears expect further losses, while some holders are buying dips and arguing for a rebound; proposed explanations such as macro and political concerns remain speculative.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Labs Q3 results are driving attention: revenue, backlog and forward guidance beat expectations, while the EPS miss and Neutrons delay to no earlier than 2027 weighed on the report. Traders are split between bullish views that demand and contracts support the long-term story and concerns about losses, execution risk and the post-earnings pullback.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys QNX collaboration with Valeo on a front-view smart-camera platform, backed by design wins with multiple Chinese automakers and planned production, is driving attention. Traders see it as evidence of QNX growth in automotive and other embedded markets, while others remain cautious about whether new wins will translate into meaningful revenue and debate the stocks recent strength.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

MARAs quarterly results and AI/HPC pivot are driving attention: earnings beat, but revenue missed amid weaker Bitcoin prices, while the company highlighted a GPU-services contract, debt reduction and a share-repurchase authorization. Traders are divided between welcoming these steps as evidence of progress and questioning the quality of reported earnings and the lack of signed tenants for its broader data-center plans.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

Occidentals Q3 earnings beat estimates, but the response is muted as traders focus on weaker sequential cash flow, softer oil prices and lower production. Some view debt reduction and the stronger balance sheet positively, while others are frustrated by the lack of buybacks and delayed shareholder returns.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics quarterly report showed strong BRIUMVI growth and a higher full-year revenue outlook, driving attention to the drugs commercial momentum. Traders were broadly bullish despite a sharp post-report pullback and recovery, while many pointed to the upcoming subcutaneous BRIUMVI Phase 3 readout as the next key catalyst; buyout and short-squeeze talk remained speculative.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HIMS Stock Tumbles After-Hours On Surprise Q3 Loss And Cut Profit Outlook: Retail Demands Answers 

Equity

The company now expects full-year 2026 revenue of $3.13 billion–$3.15 billion and lowered adjusted core profit expectations to $257 million–$277 million. 


IJH, OKTA, FTI, USFD: ETF Inflow Alert

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core S&P Mid-Cap ETF (Symbol: IJH) where we have detected an approximate $328.9 million dollar inflow -- that's a 0.3% increase week over...

HIMS Stock Jumps 5% After HHS Temporarily Clears Compounding Of Six Peptides

HHS said it will not go after state-licensed pharmacies, federal facilities, or licensed doctors for compounding six peptides—BPC-157, Epitalon, KPV, MOTS-c, Semax, and TB-500. 

Telehealth Firm Hims & Hers Seeks Dismissal Of FTC Privacy And Subscription Lawsuit

Hims argued that the agency ignored the company’s disclosures and misapplied federal law on subscriptions and privacy. 


MAT Stock Closes Flat As Southeastern Reportedly Prepares Proxy Fight To Force Sale Of The Barbie Maker

Southeastern Asset Management, a longstanding Mattel investor, is considering nominating new directors in a proxy fight aimed at forcing the company to explore a sale, Semafor reported. 


HIMS Stock Gains As Company Enters German Men’s Weight Market As Investors Watch US Peptide Compounding Policy

Hims is introducing online weight-management care for men in Germany, beginning with private consultations that can lead to prescriptions from EU-licensed clinicians. 


Noteworthy ETF Outflows: IJH, OKTA, NVT, MTSI

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core S&P Mid-Cap ETF (Symbol: IJH) where we have detected an approximate $135.1 million dollar outflow -- that's a 0.1% decrease week ov...

GME Rises After Hours As Ryan Cohen Buys Another 844K Shares Worth Near $23M

Cohen acquired 67,130 shares at $26.75 apiece and another 777,000 shares at $27, according to a filing with the Securities and Exchange Commission.


IJH, TWLO, OKTA, FTI: ETF Outflow Alert

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core S&P Mid-Cap ETF (Symbol: IJH) where we have detected an approximate $967.1 million dollar outflow -- that's a 0.8% decrease week ov...

Should iShares Core S&P Mid-Cap ETF (IJH) Be on Your Investing Radar?

iShares Trust - iShares Core S&P Mid-Cap ETF

Neutral Sentiment

<ul class="summary-bullets"><li>The company’s Q3 revenue rose 49% to $890.4 million from $599.0 million a year earlier, slightly missing consensus estimates near $892.77 million.&nbsp;</li><li>Gross margin contracted to 57% from 74%, pressured by international expansion costs and a mix shift toward lower-margin branded offerings.&nbsp;</li><li>CFO Yemi Okupe hinted at “several planned expansions to our platform in the fourth quarter.”</li></ul>&nbsp;Shares of Hims &amp; Hers Health Inc. fell 3% after hours on Monday after the telehealth provider reported a surprise third-quarter net loss, owing to a shift towards branded drugs in place of compounded ones, and reduced its full-year adjusted core profit guidance, raising investor concerns over softer near-term profitability despite solid revenue growth.<a class="mention" data-mention="$HIMS" data-symbol-id="HIMS" href="https://stocktwits.com/symbol/HIMS" target="_blank">HIMS shares</a> closed the regular session down 12% and extended losses after hours.<h2 class="st-heading-2">HIMS Reports Surprise Q3 Loss And Margin Compression</h2>The company’s revenue rose 49% to $890.4 million from $599.0 million a year earlier, slightly missing consensus estimates near $892.77 million, according to data from Fiscal AI.The company swung to a net loss of $33.0 million, or $0.14 per share, from net income of $15.8 million in the year-ago quarter. Analysts had expected a profit of roughly $0.06.Gross margin contracted to 57% from 74%, pressured by international expansion costs and a mix shift toward lower-margin branded offerings, particularly GLP-1 weight-loss drugs, that began earlier this year.Subscribers grew 13% to nearly 2.8 million in the quarter, while monthly revenue per average subscriber climbed 30% to $105. U.S. revenue advanced 21% to $657.1 million; rest-of-world revenue surged 321% to $233.3 million, underscoring the company’s overseas push.<h2 class="st-heading-2">HIMS Guidance Reduced</h2>The company now expects full-year 2026 revenue of $3.13 billion–$3.15 billion and lowered adjusted core profit expectations to $257 million–$277 million, implying an 8%–9% margin. The company had previously guided to revenue in the range of $3.1 billion to $3.3 billion and adjusted core profit of $275 million to $325 million.Fourth-quarter guidance calls for revenue of $875 million–$895 million and adjusted core profit of $70 million–$90 million, implying an 8%–10% margin.CFO Yemi Okupe said that the company is making “deliberate strategic decisions to position Hims &amp; Hers for durable, multi-year growth.”“We delivered those (Q3) results while intentionally pacing marketing spend ahead of several planned expansions to our platform in the fourth quarter, which we expect will set us up well heading into 2027,” they said, hinting at increased near-term investments.<h2 class="st-heading-2">The Pivot To Branded Drugs</h2>Hims &amp; Hers has accelerated a strategic shift away from higher-margin compounded GLP-1 medications toward FDA-approved branded weight-loss drugs, a pivot that began in earnest with its March 2026 collaboration with Novo Nordisk to bring Ozempic and Wegovy onto the platform while winding down broad marketing of compounded alternatives.Earlier this month, the company also announced an agreement allowing patients to access Eli Lilly &amp; Co’s Zepbound and Foundayo directly on the Hims &amp; Hers platform at self-pay prices. The company has paired the branded push with rapid international expansion primarily through acquisitions of local digital-health platforms.<h2 class="st-heading-2">How Did HIMS Retail Traders React?</h2>On Stocktwits, retail sentiment around HIMS stock jumped from 'neutral' to 'extremely bullish' territory over the past 24 hours, while message volume jumped from 'high' to 'extremely high' levels.A Stocktwits user expressed disappointment at the earnings miss.<stembedurl>https://stocktwits.com/Steve_TheBull_Rogers/message/668619300</stembedurl>Another user said that management needs to explain its interest in new clinical areas such as peptides, and its marketing spend and acquisition rationale.<stembedurl>https://stocktwits.com/Fast0rer/message/668620174</stembedurl>HIMS stock has dropped 29% year-to-date.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/spcx-stock-rises-as-space-x-advances-24-b-texas-data-center-and-gas-plant-plans/cNGrFNUR97B">SPCX Stock Rises As SpaceX Advances $24B Texas Data Center And Gas Plant Plans</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, the Hims & Hers Health logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

The company now expects full-year 2026 revenue of $3.13 billion–$3.15 billion and lowered adjusted core profit expectations to $257 million–$277 million. 

HIMS Stock Tumbles After-Hours On Surprise Q3 Loss And Cut Profit Outlook: Retail Demands Answers

iShares Core S&P Mid-Cap ETF

Vanguard Total Stock Market ETF

Buying the dip

Selling or trimming

Holding

Waiting for the investigation results to decide

Nvidia ($NVDA) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Stocktwits

) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Feed

News

Sentiment

Fundamentals

Info

IJH iShares Core S&P Mid-Cap ETF

Fundamentals

Latest IJH News